C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1992
03/31/1992	US5100807 Fluorescence polarization immunoassay
03/31/1992	US5100788 Method of producing and isolating igg-binding protein a fusion peptides and a vector therefor
03/31/1992	US5100378 Enhancement of target cell localization of lymphoid cells
03/31/1992	CA1298219C Homogeneous immune interferon fragment
03/29/1992	WO1992006204A1 Surface expression libraries of heteromeric receptors
03/29/1992	WO1992005799A1 Method for inhibiting the infectivity of human immunodeficiency virus
03/29/1992	CA2092802A1 Surface expression libraries of heteromeric receptors
03/29/1992	CA2091253A1 Method for inhibiting the infectivity of human immunodeficiency virus
03/28/1992	WO1992006199A2 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides
03/28/1992	WO1992006115A1 Antagonists of human gamma interferon
03/28/1992	WO1992005804A1 Chelating agents
03/28/1992	CA2092546A1 Antibody inductor peptides inhibiting retrovirus of the hiv type and antibodies specific for said peptides
03/28/1992	CA2092541A1 Antagonists of human gamma interferon
03/28/1992	CA2092434A1 Chelating agents
03/28/1992	CA2052283A1 Recombinant hybrid immunoglobulin molecules and method of use
03/26/1992	CA2048582A1 Monoclonal antibody for detecting htlv-i, htlv-ii and stlv-i viruses
03/25/1992	EP0476875A2 Process for the purification and concentration of biologically active materials
03/25/1992	EP0476408A1 Chemical conjugation of morpholino anthracyclines to antibodies
03/25/1992	EP0476226A1 Monoclonal antibody against human IgE
03/25/1992	EP0476130A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
03/25/1992	EP0476015A1 Recombinant alzheimer's amyloid protein
03/25/1992	EP0476014A1 Very large scale immobilized polymer synthesis.
03/25/1992	EP0476007A1 Catalytic antibodies
03/25/1992	CA2052022A1 Peptides having thrombospondin-like activity and their therapeutic use
03/25/1992	CA2051749A1 Cell adhesion molecule
03/25/1992	CA2050817A1 Hiv-neutralizing rat monoclonal antibodies against pb-1
03/24/1992	US5099005 Desialylating immunoglobulins and fragmenting
03/24/1992	US5099004 Antibodies such as monoclonal antibodies
03/24/1992	US5098997 Vaccines for Haemophilus influenzae
03/24/1992	US5098829 Immunoadsorbents
03/24/1992	US5098827 Novel bacterial markers for pathogenic group B streptococci
03/24/1992	CA1297819C Hybridoma tumor cell lines and their monoclonal antibodies to theumatin
03/24/1992	CA1297818C Anti-urokinase monoclonal antibody, matrix bearing it, test method and biochemical test kits which use it
03/24/1992	CA1297817C Monoclonal antibody specific to a common determinant site of neutrophilsand eosinophils
03/24/1992	CA1297816C Platelet function inhibiting monoclonal antibody fragment
03/24/1992	CA1297815C Fibrinogen blocking monoclonal antibody
03/19/1992	WO1992005273A1 Gene therapy for cystic fibrosis
03/19/1992	WO1992004465A1 Immobilization of organic macromolecules or biopolymers in a polymer membrane
03/19/1992	WO1992004464A1 Monoclonal antibodies against tenascin
03/19/1992	WO1992004460A1 Genetically engineered coccidiosis vaccine
03/19/1992	WO1992004448A2 Human mitochondrial nad(p)+-dependent malate enzyme
03/19/1992	WO1992004446A1 Cloning of chicken anaemia dna
03/19/1992	WO1992004443A2 B cell deficient transgenic fbv/n mice
03/19/1992	WO1992004442A1 Glial antiproliferative proteins
03/19/1992	WO1992004440A1 B cell deficient transgenic non-human animals
03/19/1992	WO1992004380A1 Specific binding agents
03/19/1992	WO1992004376A1 Novel chemotactic factor
03/19/1992	WO1992004375A1 Hrsv vaccine
03/19/1992	WO1992004052A1 Modified antibodies with controlled clearance time
03/19/1992	WO1992004051A1 Monoclonal antibody active against the interleukin-2 receptor
03/19/1992	WO1992004033A1 Methods for inhibiting rejection of transplanted tissue
03/19/1992	WO1992003918A1 Transgenic non-human animals capable of producing heterologous antibodies
03/19/1992	WO1992003917A1 Homologous recombination in mammalian cells
03/19/1992	DE4028955A1 Monoklonale antikoerper gegen den interleukin 2-rezeptor Monoclonal antibodies against the interleukin 2 receptor
03/19/1992	CA2090473A1 Homologous recombinatin in mammalian cells
03/18/1992	EP0475478A1 Haemophilus paragallinarum vaccine
03/18/1992	EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides.
03/18/1992	EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods
03/18/1992	EP0474764A1 Method to treat rheumatoid arthritis
03/18/1992	EP0474676A1 Production of ibdv vp2 in highly immunogenic form
03/18/1992	EP0474646A1 Bordetella vaccines
03/18/1992	EP0474645A1 Protein complex
03/18/1992	EP0420894A4 Large scale method for purification of high purity heparinase
03/18/1992	EP0303625B1 Polypeptide competitor for immunoglobulin e
03/18/1992	EP0265496B1 Flecainide derivatives and their use in immunoassays
03/18/1992	EP0050129B1 Monoclonal antibody
03/18/1992	CN1059471A Heamophilus paragallinarum vaccine
03/18/1992	CA2048089A1 Chemical conjugation of morpholino anthracyclines to antibodies
03/17/1992	US5096838 Fluorescent tracers for detection of barbiturates and for antiserums
03/17/1992	US5096816 Increasing production of terminally sialylated secreted monoclonal antibody in an ammonia cell culture by growing the cells at a pH of 7.2-7.4, gradually decreasing pH to 6.7-7.05 and maintaining during production phase, harvesting
03/17/1992	US5096810 Monoclonal antibodies for diagnosis of hairy cell leukemia
03/17/1992	US5096704 Administering antagonist to Interleukin-5 which is a nonhuman monoclonal antibody
03/17/1992	US5096703 Administering aminoguanidine or its salts; oral rinse, tooth paste
03/17/1992	CA1297437C Process for the preparation of protease inhibitors
03/13/1992	WO1992004372A1 Active site of interleukin-8: polypeptide analogs and antibodies
03/13/1992	CA2091558A1 Active site of interleukin-8: polypeptide analogs and antibodies
03/12/1992	WO1992004381A1 Novel antibodies for treatment and prevention of infection in animals and man
03/12/1992	DE4104128A1 Determn. of glycogen phosphorylase isoenzyme BB - by sandwich-type enzyme immunoassay using selected monoclonal antibodies
03/12/1992	DE4028618A1 Human mitochondrial NAD(P)-dependent malate enzyme - used to study formation of pyruvate from aminoacid(s) in tumour cells
03/12/1992	CA2091335A1 Antibodies for treatment and prevention of infection in animals and man
03/11/1992	EP0474416A2 Antigenic material, antibodies raised thereto, hybridomas for producing antibodies, and immunoassays incorporating such antibodies
03/11/1992	EP0474323A1 Reducing chelants, their complexes with technetium and rhenium, method for their preparation and their use in diagnosis and therapy
03/11/1992	EP0474313A2 Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations
03/11/1992	EP0473961A2 Immunoassay reagents and method for determining cyclosporine
03/11/1992	EP0473725A1 Composition and method to detect sensitivity to alpha interferon therapy
03/11/1992	EP0473721A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
03/11/1992	EP0473651A1 Monoclonal antibodies which recognise malignant cells from bladder carcinomas
03/11/1992	EP0435877A4 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response
03/11/1992	CN1059278A 抗体共轭物 Antibody conjugate
03/10/1992	US5095097 Diagnostics
03/10/1992	US5095094 A43 kDa antigenic protein of Bordetella recognized by polyclonal antibodies to adenylate cyclase but devoid of calmodulin-activatable adenylate cyclase activity
03/10/1992	US5094951 Genetic engineering
03/10/1992	US5094949 Side effect reduction
03/10/1992	US5094941 Monoclonal antibodies to PDGF
03/10/1992	CA1297049C Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
03/10/1992	CA1297048C Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein
03/06/1992	CA2049129A1 Haemophilus paragallinarum vaccine
03/05/1992	WO1992004463A1 Cd58-specific monoclonal antibodies and their use
03/05/1992	WO1992004015A2 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR
03/05/1992	WO1992004014A2 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR

1 ... 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 ... 1494